Atlas Trials

PDR and SKYD of Dyslipidemia's Characteristics From the Oxidative Stress Enhancement Caused by Inhibition of Serine Metabolic Pathway

Clinical trial NCT04909489 · UNKNOWN

Trial details

NCT number
NCT04909489
Sponsor
Dongzhimen Hospital, Beijing
Status
UNKNOWN
Study type
OBSERVATIONAL
Traditional Chinese MedicineDyslipidemiasSyndrome
Start date
2021-04-21
Primary completion
2023-03-31
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.